When the large blood vessels develop vasculitis, it is an independent disease, such as Takayasu's or giant cell (also called cranial or temporal) arteritis. This type of vasculitis has completely ...

Patients with LVV and IBD present with distinct clinical characteristics, including earlier onset and more severe vascular involvement.

Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.

The Food and Drug Administration (FDA) has approved Romvimza ™ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical ...

Giant Cell Arteritis (GCA) Formerly called temporal arteritis, GCA is the most common form of vasculitis. It primarily affects white women and older adults (over 50), causing inflammation in the ...

Autoimmune vasculitis is a group of conditions that cause blood vessel inflammation. Examples include Kawasaki disease and giant cell arteritis. They develop as a result of an overreaction of your ...

In this study, we have investigated how these luminal myofibroblasts develop during Kawasaki disease (KD), a paediatric vasculitis typically involving ... Takayasu’s arteritis and Giant Cell arteritis ...

induces significant and sustained remission in people with new-onset or relapsing giant cell arteritis (GCA). The primary endpoint of sustained remission — the absence of GCA signs or symptoms ...

Temporal artery ultrasound alone was sufficient to accurately diagnose giant cell arteritis (GCA ... for patients with suspected large vessel vasculitis, and the 2022 American College of ...

A new Series in The Lancet Rheumatology discusses the pathological polarisations seen in the three major vasculitides—antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, giant cell ...

In the Annals of Internal Medicine Clinical Cases, researchers presented the case of a patient with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) that initially masqueraded as ...